# Carvedilol PAH A Pilot Study of Efficacy and Safety

> **NCT02120339** · PHASE1 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 5 (actual)

## Conditions studied

- Pulmonary Hypertension
- Cardiac MRI <40

## Interventions

- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT02120339
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120339, "Carvedilol PAH A Pilot Study of Efficacy and Safety". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02120339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*